Platelet-rich fibrin modulates the expression of extracellular signal-regulated protein kinase and osteoprotegerin in human osteoblasts

Journal of Biomedical Materials Research - Part A

Volumn 95, Issue 1, 2010, Pages 327-332

  Chang, I Chang ^a,b   Tsai, Chung Hung ^b   Chang, Yu Chao ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Choukroun's technique; Osteoblast; Osteoprotegerin; Platelet rich fibrin; Proliferation

Indexed keywords

BLOOD COLLECTION; BONE FORMATION; BONE REGENERATION; CHOUKROUN'S TECHNIQUE; CLINICAL APPLICATION; COLORIMETRIC ASSAYS; EXTRACELLULAR SIGNAL-REGULATED PROTEIN KINASE; HIGH POTENTIAL; HUMAN OSTEOBLAST; INCUBATION PERIODS; NUCLEAR FACTOR KAPPAB; OSTEOBLAST CELL LINE; OSTEOBLAST PROLIFERATION; OSTEOPROTEGERIN; PLATELET ACTIVATION; PROLIFERATION; RECEPTOR ACTIVATOR; WESTERN BLOTS;

BLOOD; BONE; CALCIUM; CALCIUM CHLORIDE; CELL CULTURE; CELL PROLIFERATION; CHEMICAL ACTIVATION; PHOSPHORYLATION; PLATELETS; PROTEINS; TISSUE ENGINEERING;

OSTEOBLASTS;

FIBRIN; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PLATELET RICH FIBRIN; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELL STIMULATION; COLORIMETRY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INCUBATION TIME; OSSIFICATION; OSTEOBLAST; PROTEIN EXPRESSION; THROMBOCYTE; WESTERN BLOTTING; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; KINETICS; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE; ASSAY; BLOOD SAMPLING; BONE REGENERATION; CELL LINE; NORMAL HUMAN; PROTEIN PHOSPHORYLATION; VOLUNTEER;

BLOOD PLATELETS; CELL LINE, TUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBRIN; HUMANS; KINETICS; OSTEOBLASTS; OSTEOPROTEGERIN; PHOSPHORYLATION; RANK LIGAND;

EID: 77956478458     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32839     Document Type: Article

References (34)

1. Giannobile WV. Periodontal tissue engineering by growth factors. Bone 1996;19:23-37.
2. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): A second generation platelet concentrate. Part I: Technological concept and evolution. Oral Surg Oral Med Oral Path Oral Radiol Endod 2006;101:E37-E44.
3. Choukroun J, Adda F, Schoeffer C, Vervelle A. PRF: An opportunity in perio-implantology (in French). Implantodontie 2000;42:55-62.
4. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part II: Platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:E45-E50.
5. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part III: Leucocyte activation: A new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:E51-E55.
6. Dohan Ehrenfest DM, Diss A, Odin G, Doglioli P, Hippolyte MP, Charrier JB. In vitro effects of Choukroun's PRF (platelet-rich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:341-352.
7. He L, Lin Y, Hu X, Zhang Y, Wu H. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:707-713.
8. Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJ, Mouhyi J, Dohan DM. Plateletrich fibrin (PRF): A second-generation platelet concentrate. Part IV: Clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:E56-E60.
9. Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJ, Mouhyi J, Dohan DM. Plateletrich fibrin (PRF): A second-generation platelet concentrate. Part V: Histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:E299-E303.
10. Diss A, Dohan DM, Mouhyi J, Mahler P. Osteotome sinus floor elevation using Choukroun's platelet-rich fibrin as grafting material: A 1-year prospective pilot study with microthreaded implants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:572-579.
11. Mazor Z, Horowitz RA, Del Corso M, Prasad HS, Rohrer MD, Dohan Ehrenfest DM. Sinus floor augmentation with simultaneous implant placement using Choukroun's PRF (platelet-rich fibrin) as sole grafting material: A radiological and histological study at 6 months. J Periodontol 2009;80:2056-2064.
12. Simonpieri A, Del Corso M, Sammartino G, Dohan Ehrenfest DM. The relevance of Choukroun's platelet rich fibrin (PRF) and metronidazole during complex maxillary rehabilitations using bone allograft? Part I: A new grafting protocol. Implant Dent 2009;18:102-111.
13. Simonpieri A, Del Corso M, Sammartino G, Dohan Ehrenfest DM. The relevance of Choukroun's platelet rich fibrin (PRF) and metronidazole during complex maxillary rehabilitations using bone allograft? Part II: Implant surgery, prosthodontics and survival. Implant Dent 2009;18:220-229.
14. Choukroun JI, Braccini F, Diss A, Giordano G, Doglioli P, Dohan DM. Influence of platelet rich fibrin (PRF) on proliferation of human preadipocytes and tympanic keratinocytes: A new opportunity in facial lipostructure (Coleman's technique) and tympanoplasty? Rev Laryngol Otol Rhinol (Bord) 2007;128:27-32.
15. Braccini F, Dohan DM. The relevance of Choukroun's platelet rich fibrin (PRF) during facial aesthetic lipostructure (Coleman's technique): Preliminary results. Rev Laryngol Otol Rhinol (Bord) 2007;128:255-260.
16. Segar R, Krebs EG. The MAPK signaling cascade. FASEB J 1995;9:726-735.
17. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK. JNK, and p38 protein kinases. Science 2002;298:1911-1912.
18. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-176.
19. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/ RANKL. Proc Natl Acad Sci USA 1998;95:3597-3602.
20. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999;402:304-309.
21. Huang FM, Lee SS, Yang SF, Chang YC. Up-regulation of receptor activator nuclear factor-kappa B ligand expression by root canal sealers in human osteoblastic cells. J Endod 2009;35:363-366.
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63. (Pubitemid 14203433)
23. Huang FM, Tai KW, Chou MY, Chang YC. Resinous perforation repair materials inhibit the growth, attachment, and proliferation of human gingival fibroblasts. J Endod 2002;28:291-294.
24. Huang CY, Chen JH, Tsai CH, Kuo WW, Liu JY, Chang YC. Regulation of extracellular signal-regulated protein kinase signaling in human osteosarcoma cells stimulated with nicotine. J Periodont Res 2005;40:176-181.
25. Chen SS, Huang FM, Lee SS, Li MZ, Chang YC. The upregulation of receptor activator NF-κB ligand expression by interleukin-1α and Porphyromonas endodontalis in human osteoblastic cells. Int Endodont J. 2009;42:375-380.
26. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotech 2009;27:158-167.
27. Nelissen JMDT, Torensma R, Pluyter M, Adema GJ, Raymakers RAP, Van Kooyk Y, Figdor CG. Molecular analysis of its hematopoiesis supporting osteoblastic cell line U2-OS. Exp Hematol 2000;28:422-432.
28. Dohan Ehrenfest DM, de Peppo GM, Doglioli P, Sammartino G. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): A gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 2009; 27:63-69.
29. Mehrotra M, Krane SM, Walters K, Pilbeam C. Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells. J Cell Biochem 2004;93:741-752.
30. Kim SJ, Kim SY, Kwon CH, Kim YK. Differential effect of FGF and PDGF on cell proliferation and migration in osteoblastic cells. Growth Factors 2007;25:77-86.
31. Lai CF, Cheng SL. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells. J Biol Chem 2002;277:15514-15522.
32. McCarthy HS, Williams JH, Davie MW, Marshall MJ. Platelet-derived growth factor stimulates osteoprotegerin production in osteoblastic cells. J Cell Physiol 2009;218:350-354.
33. Murakami T, Yamamoto M, Ono K, Nishikawa M, Nagata N, Motoyoshi K, Akatsu T. Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. Biochem Biophys Res Commun 1998;252:747-752.
34. Schwartz Z, Olivares-Navarrete R, Wieland M, Cochran DL, Boyan BD. Mechanisms regulating increased production of osteoprotegerin by osteoblasts cultured on microstructured titanium surfaces. Biomaterials 2009;30:3390-3396.